CUSIP 037326105COMANTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
37 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Almitas Capital LLC | 1.48M | $1.69M | +50.8K | Added |
| 2 | Vanguard Group Inc | 1.08M | $1.23M | 0 | Held |
| 3 | Pfizer Inc | 715.3K | $815.4K | 0 | Held |
| 4 | Stonepine Capital Management, LLC | 627.7K | $715.5K |
| +63.8K |
| Added |
| 5 | Peapod Lane Capital LLC | 593.4K | $676.5K | +4.2K | Added |
| 6 | Bank Of Nova Scotia | 459.2K | $523.5K | 0 | Held |
| 7 | Landscape Capital Management, L.L.C. | 431.8K | $492.2K | −24.7K | Reduced |
| 8 | Bank Of Montreal /Can/ | 422.1K | $481.2K | 0 | Held |
| 9 | Bank Of America Corp /De/ | 385.3K | $439.3K | +2 | Added |
| 10 | Renaissance Technologies LLC | 338.6K | $386.0K | −47.0K | Reduced |
See every fund holding An2 Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders